Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
145 hedge funds and large institutions have $421M invested in Flexion Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 43 reducing their positions, and 17 closing their positions.
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
23% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 43
3% more funds holding
Funds holding: 141 → 145 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less capital invested
Capital invested by funds: $580M → $421M (-$159M)
28% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $2.55M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Clearline Capital
New York
|
+$16.1M |
| 2 |
Two Sigma Investments
New York
|
+$8.25M |
| 3 |
Two Sigma Advisers
New York
|
+$7.28M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.99M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$44.1M |
| 2 |
VVM
Versant Venture Management
San Francisco,
California
|
-$29M |
| 3 |
Neuberger Berman Group
New York
|
-$7.45M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$7.39M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$6.69M |
FLXN Hedge Fund Activity: Q1 2021 in Review
145 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q1 2021, worth a combined $421M — down 27% from $580M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new FLXN positions and 17 closed out — a net gain of 4 holders — while 53 added to existing stakes and 43 trimmed.
The largest buyer was Clearline Capital, opening a new position worth an estimated $16.1M. The largest seller was Capital World Investors, exiting entirely with an estimated $44.1M sold.
- 145 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q1 2021, up from 141 in Q4 2020.
- Funds reported $421M of Flexion Therapeutics, Inc. stock for Q1 2021, down 27% quarter-over-quarter.
- 21 funds opened new Flexion Therapeutics, Inc. positions in Q1 2021 and 17 closed out, a net change of +4 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q1 2021 was Clearline Capital, an estimated $16.1M added.
- The largest Flexion Therapeutics, Inc. seller in Q1 2021 was Capital World Investors, an estimated $44.1M sold.
Based on aggregated 13F filings for Q1 2021.